BlackRock’s Oncternal Therapeutics, Inc. Common Stock ONCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $52.4K | Buy |
|
|||||
|
2024
Q2 | $299K | Hold |
|
|||||
|
2024
Q1 | $354K | Sell |
|
|||||
|
2023
Q4 | $421K | Hold |
|
|||||
|
2023
Q3 | $236K | Sell |
|
|||||
|
2023
Q2 | $271K | Sell |
|
|||||
|
2023
Q1 | $715K | Sell |
|
|||||
|
2022
Q4 | $1.01M | Buy |
|
|||||
|
2022
Q3 | $887K | Sell |
|
|||||
|
2022
Q2 | $1.11M | Sell |
|
|||||
|
2022
Q1 | $4.33M | Sell |
|
|||||
|
2021
Q4 | $7.26M | Sell |
|
|||||
|
2021
Q3 | $13.3M | Sell |
|
|||||
|
2021
Q2 | $15.2M | Buy |
|
|||||
|
2021
Q1 | $8.95M | Buy |
|
|||||
|
2020
Q4 | $1.68M | Buy |
|
|||||
|
2020
Q3 | $110K | Sell |
|
|||||
|
2020
Q2 | $185K | Buy |
|
|||||
|
2020
Q1 | $103K | Hold |
|
|||||
|
2019
Q4 | $139K | Sell |
|
|||||
|
2019
Q3 | $191K | Buy |
|
|||||
|
2019
Q2 | $219K | Sell |
|
|||||
|
2019
Q1 | $547K | Sell |
|
|||||
|
2018
Q4 | $364K | Sell |
|
|||||
|
2018
Q3 | $755K | Buy |
|
|||||
|
2018
Q2 | $5.97M | Buy |
|
|||||
|
2018
Q1 | $3.02M | Sell |
|
|||||
|
2017
Q4 | $2.19M | Buy |
|
|||||
|
2017
Q3 | $1.44M | Buy |
|
|||||
|
2017
Q2 | $885K | Buy |
|
|||||
|
2017
Q1 | $767K | Buy |
|
|||||
|
2013
Q3 | – | Sell |
|
|||||
|
2013
Q2 | $5K | Buy |
|